These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 5591364

  • 21. [Short term treatment of Paget's disease with porcine calcitonin].
    Renier JC, Boasson M, Jallet P, Bernat M.
    Rev Rhum Mal Osteoartic; 1973 Oct; 40(10):557-63. PubMed ID: 4797550
    [No Abstract] [Full Text] [Related]

  • 22. [Diagnostic procedure in osteodystrophia deformans Paget].
    Jesserer H, Zita G, Drexler H.
    Acta Med Austriaca; 1977 Oct; 4(4-9):169-71. PubMed ID: 610340
    [Abstract] [Full Text] [Related]

  • 23. [Decrease of the coefficient of intestinal calcium absorption with normal blood levels of 1,25-dihydroxyvitamin D and decreasing levels of 24,25-dihydroxyvitamin D in Paget's disease of bone].
    Traba ML, Climent P, Rapado A, de la Piedra C, Díaz Curiel M.
    Rev Clin Esp; 1986 Nov; 179(8):401-3. PubMed ID: 3494277
    [No Abstract] [Full Text] [Related]

  • 24. Sustained biochemical effects of short treatment of Paget's disease of bone with dichloromethylene diphosphonate.
    Chapuy MC, Charhon SA, Meunier PJ.
    Metab Bone Dis Relat Res; 1983 Nov; 4(6):325-8. PubMed ID: 6229683
    [Abstract] [Full Text] [Related]

  • 25. [Deoxypyridinoline and other biochemical markers of bone resorption in distinct pathologies].
    Rivero Marcotegui A, Palacios Sarrasqueta M, Grijalba Uche A, Martínez Rodríguez JL, Sorbet Zubiría MJ, García Merlo S.
    Rev Clin Esp; 1997 Jun; 197(6):389-92. PubMed ID: 9304127
    [Abstract] [Full Text] [Related]

  • 26. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.
    Kaddam IM, Iqbal SJ, Holland S, Wong M, Manning D.
    Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():327-30. PubMed ID: 7979096
    [Abstract] [Full Text] [Related]

  • 27. [The value of the calcitonin test in Paget's disease of bone].
    D'Amore M, Bozzi A, Telesca ML, Carrozzo M.
    Minerva Med; 1981 Apr 07; 72(14):865-8. PubMed ID: 7219796
    [Abstract] [Full Text] [Related]

  • 28. Experiences in the treatment of Paget's disease of bone with mithramycin.
    Ryan WG, Schwartz TB, Northrop G.
    JAMA; 1970 Aug 17; 213(7):1153-7. PubMed ID: 5468261
    [No Abstract] [Full Text] [Related]

  • 29. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
    Ghiringhelli G, Fogel M, Varela de Rodríguez J, Casco C, Mautelén C, Nusimovich B.
    Medicina (B Aires); 1982 Aug 17; 42(1):16-20. PubMed ID: 6813634
    [No Abstract] [Full Text] [Related]

  • 30. [Paget's disease of the proximal ulna--a rare monostotic manifestation].
    Klepsch M, Seidel T, Runkel M.
    Z Orthop Ihre Grenzgeb; 1997 Aug 17; 135(3):258-60. PubMed ID: 9334082
    [Abstract] [Full Text] [Related]

  • 31. [Chromatographic analysis of urinary amino acids in Paget's disease. I : Biochemical study. Isolation and amino acid composition of a urinary peptide specific to this bone disease].
    Fabier JL, Viau M, Constans J, Clerc A.
    Rev Rhum Mal Osteoartic; 1976 Apr 17; 43(4):249-53. PubMed ID: 1273474
    [Abstract] [Full Text] [Related]

  • 32. Measurement of skeletal blood flow in normal man and in patients with Paget's disease of bone.
    Wootton R, Reeve J, Veall N.
    Calcif Tissue Res; 1976 Aug 17; 21 Suppl():380-5. PubMed ID: 782666
    [No Abstract] [Full Text] [Related]

  • 33. Paget's disease of bone (osteitis deformans): symptomatic lesions and bone scan.
    Khairi MR, Wellman HN, Robb JA, Johnston CC.
    Ann Intern Med; 1973 Sep 17; 79(3):348-51. PubMed ID: 4748251
    [No Abstract] [Full Text] [Related]

  • 34. [Paget's disease of the bones: diagnosis and treatment].
    Jacobs JW, Huisman AM, van Paassen HC, Bijlsma JW.
    Ned Tijdschr Geneeskd; 1999 Apr 03; 143(14):719-25. PubMed ID: 10347626
    [Abstract] [Full Text] [Related]

  • 35. [Biological and isotope explorations in Paget's disease of bone].
    Dell'Anno R, Eisinger J, Recordier AM.
    Rhumatologie; 1971 Apr 03; 23(4):119-39. PubMed ID: 4254981
    [No Abstract] [Full Text] [Related]

  • 36. Evidence of a generalised connective-tissue defect in Paget's disease of bone.
    Francis MJ, Smith R.
    Lancet; 1974 May 04; 1(7862):841. PubMed ID: 4132793
    [No Abstract] [Full Text] [Related]

  • 37. Effects of calcitonin in Paget's disease and polyostotic fibrous dysplasia.
    Bell NH, Avery S, Johnston CC.
    J Clin Endocrinol Metab; 1970 Sep 04; 31(3):283-90. PubMed ID: 4916538
    [No Abstract] [Full Text] [Related]

  • 38. Urinary excretion of glycosaminoglycans and hydroxyproline in Paget's disease of bone, compared with neoplastic invasion of bone.
    Bower L, Manley G.
    J Clin Pathol; 1981 Oct 04; 34(10):1097-101. PubMed ID: 7309892
    [Abstract] [Full Text] [Related]

  • 39. Biochemical markers of bone turnover in Paget's disease of bone.
    Eastell R.
    Bone; 1999 May 04; 24(5 Suppl):49S-50S. PubMed ID: 10321928
    [No Abstract] [Full Text] [Related]

  • 40. Zoledronate in the treatment of Paget's disease.
    Siris E.
    Br J Clin Pract Suppl; 1996 Sep 04; 87():19-20; discussion 22. PubMed ID: 8995014
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.